Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial
急性冠脉综合征后,他汀类药物和阿利西尤单抗可短暂地使低密度脂蛋白胆固醇水平降至极低,这与心血管风险降低相关:ODYSSEY OUTCOMES 试验
期刊:European Heart Journal
影响因子:35.6
doi:10.1093/eurheartj/ehad144
Schwartz, Gregory G; Szarek, Michael; Bhatt, Deepak L; Bittner, Vera A; Bujas-Bobanovic, Maja; Diaz, Rafael; Fazio, Sergio; Fras, Zlatko; Goodman, Shaun G; Harrington, Robert A; Jukema, J Wouter; Manvelian, Garen; Pordy, Robert; Ray, Kausik K; Scemama, Michel; White, Harvey D; Steg, Ph Gabriel